Tryvio — Blue Cross Blue Shield of Texas
other FDA labeled indication
Initial criteria
- BCBS NM Fully Insured or NM HIM member requests approved when ALL of the following:
 - 1. The patient does NOT have any FDA labeled contraindications to the requested agent AND
 - 2. The requested indication is a rare disease AND
 - 3. ONE of the following:
 - A. The patient has another FDA labeled indication for the requested agent and route of administration OR
 - B. The patient has another indication that is supported in compendia for the requested agent and route of administration
 - OR
 - Member resides in Ohio AND plan is Fully Insured or HIM Shop (SG) AND ALL of the following:
 - 1. The patient does NOT have any FDA labeled contraindications to the requested agent AND
 - 2. ONE of the following:
 - A. The patient has another FDA labeled indication for the requested agent and route of administration OR
 - B. The patient has another indication that is supported in compendia for the requested agent and route of administration OR
 - C. The prescriber has submitted TWO articles from major peer-reviewed professional medical journals supporting proposed use(s) as generally safe and effective (case studies not acceptable)
 
Approval duration
12 months